Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study

Digestive and Liver Disease

Volumn 32, Issue 4, 2000, Pages 294-301

  O'Sullivan, M A ^a   O'Morain, C A ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Intestinal flora; Irritable bowel syndrome; Lactobacillus GG; Randomised controlled trial

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFECATION; DIARRHEA; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LACTOBACILLUS CASEI; MALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION;

EID: 0033921870     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(00)80021-3     Document Type: Article

References (53)

1. Bergin A, Donnelly T, McKendrick M, Read N. Changes in anorectal function in persistent bowel disturbance following salmonella gastroenteritis. Eur J Gastroenterol Hepatol 1993;5:617-20.
2. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996;347:150-3.
3. Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998;10:59-62.
4. Creed F, Craig T, Fanner R. Functional abdominal pain, psychiatric illness, and life events. Gut 1988;29:235-42.
5. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992;33:825-30.
6. Hislop IG. Psychological significance of the irritable colon syndrome. Gut 1971;12:452-7.
7. Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 1988;94:1150-6.
8. Jones VA, McLaughlan P, Shorthouse M, Workman E, Hunter JO. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982;2:1150-6.
9. Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099-104.
10. Parker TJ, Naylor SJ, Riordan AM, Hunter JO. Management of patients with food intolerance in irritable bowel syndrome: the development and use of an exclusion diet. J Human Nutr Dietet 1995;8:159-66.
11. Hawthorne B, Lambert S, Scott D, Scott B. Food intolerance and the irritable bowel syndrome. J Human Nutr Dietet 1991;3:19-23.
12. Hunter JO, Workman E, Alun Jones V. The role of diet in the management of irritable bowel syndrome. In: Gibson PR, Jewell DP, editors. Topics in gastroenterology. London, UK: Blackwell Scientific Publications; 1985. p. 305-13.
13. Gorard DA, Gomborone JE, Libby GW, Farthing MJ. Intestinal transit in anxiety and depression. Gut 1996;39:551-5.
14. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991;32:73-9.
15. El Oufir L, Flourie B, Bruley des Varannes S, Barry JL, Cloarec D, et al. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut 1996;38:870-7.
16. Corthier G. Antibiotic-associated diarrhoea: treatment by living organisms given by the oral route (probiotics). In: Fuller R, editor. Probiotics. 2. Applications and practical aspects. London: Chapman & Hall; 1997. p. 40-64.
17. Winits M, Seedman DA, Graff J. Studies in metabolic nutrition employing chemically defined diets. I. Extended feeding of normal human adult males. Am J Clin Nutr 1970;23:525-45.
18. Sharma R, Schumacher U, Ronaasen V, Coates M. Rat intestinal mucosal responses to a microbial flora and different diets. Gut 1995;36:209-14.
19. Raibaud P. Bacterial interactions in the gut. In: Fuller R, editor. Probiotics. The scientific basis. London, UK: Chapman & Hall; 1992. p. 9-28.
20. Bayliss CE, Bradley HK, Jones VA, Hunter JO. Some aspects of colonic microbial activity in irritable bowel syndrome associated with food intolerance. Ann 1st Super Sanità 1986;22:959-63.
21. Hunter JO. Food intolerance and the irritable bowel syndrome. In: Read NW, editor. Irritable bowel syndrome. Oxford: Blackwell Scientific Publications; 1991. p. 203-19.
22. Alun-Jones V, Wilson AJ, Hunter JO, Robinson RE. The aetiological role of antibiotic prophylaxis with hysterectomy in irritable bowel syndrome. J Obstet Gynaecol 1984;5(Suppl 4):S22-3.
23. Blasari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982;5:185-94.
24. Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on a numbers of fecal microorganisms in man. Gastroenterology 1967;53:845-55.
25. Andrews PJ, Borody TJ. "Putting back the bugs": bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome. Med J Aust 1993;159:633-4.
26. Pearce L, Bampton PA, Borody TJ, Shortis NP. Modification of the colonie microflora using probiotics: The way forward? Gut 1997;41(Suppl 3):A63.
27. Hunter JO, Lee AJ, King TS, Barrat MEJ, Linggood MA, Blades JA. Enterococcus faecium strain PR88 - an effective probiotic. Gut 1996;38(Suppl 1):A60.
28. Niedzielin K, Kordecki H, Kosik R. New possibility in the treatment of irritable bowel syndrome probiotics as a modification of the microflora of the colon. Gastroenterology 1998;114(Suppl).
29. Fuller R. History and development of probiotics. In: Fuller R, editor. Probiotics The scientific basis. London, UK: Chapman & Hall; 1992. p. 1-8.
30. Hentges DJ. Gut flora and disease resistance. In: Fuller R, editor. Probiotics The scientific basis. London, UK: Champan & Hall; 1992. p. 87-110.
31. Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, et al. Recovery of Lactobacillus rhamnosus GG from human colonie biopsies. Lett Appl Microbiol 1997;24:361-4.
32. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987;31:1231-3.
33. Rowland IR. Metabolic interactions in the gut. In: Fuller R, editor. Probiotics. The scientific basis. London, UK: Chapman & Hall; 1992. p. 29-53.
34. Famularo G, Moretti S, Marcellini S, De Simone C. Stimulation of immunity by probiotics. In: Fuller R, editor. Probiotics. 2. Applications and practical aspects. London, UK: Chapman & Hall; 1997. p. 133-61.
35. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;37:121-8.
36. Elo S, Saxelin M, Salminen S. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains. Letts in App Microbiol 1991;13:154-6.
37. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, et al. Persistence of colonization of human colonie mucosa by a probiotic strain. Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999;65:351-4.
38. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;2:1519.
39. Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990;22:57-9.
40. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999;135:564-8.
41. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-7.
42. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990;22:53-6.
43. Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996;40:137-45.
44. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85.
45. Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998;27:155-60.
46. Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med 1975;293:524-6.
47. Galati JS, McKee DP, Quigley EM. Response to intraluminal gas in irritable bowel syndrome. Motility versus perception. Dig Dis Sci 1995;40:1381-7.
48. Thompson W, Creed F, Drossman D, Heaton K, Mazzacca G. Functional bowel disease and functional abdominal pain. Gastroenterol Internat 1992;5:75-91.
49. Talley NJ, Nyren O, Drossman DA. The irritable bowel syndrome: toward optimal design of controlled treatment trials. Gastroenterol Internat 1993;6:189-211.
50. Saxelin M, Elo S, Salminen S, Vapaatalo H. Dose response colonisation of faeces after oral administration of Lactobacillus casei strain GG. Microbial ecology in health and disease 1991;4:210-4.
51. Cann PA. An approach to the design of therapeutic trials in IBS. Scand J Gastroenterol 1987;130(Suppl):67-76.
52. Veldhuyzen van Zanten SJ, Tytgat KM, Pollak PT, Goldie J. Goodacre RL, Riddell RH, et al. Can severity of symptoms be used as outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 1993;46:273-9.
53. Halpern GM, Prindiville T, Blankernburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996;91:1579-85.